Pegapamodutide
Pegapamodutide, a cutting-edge biomedical marvel, emerges as a beacon of hope in the quest to mitigate the multifaceted manifestations of type 2 diabetes. Through intricate interactions with the esteemed GLP-1 receptors, this transcendent pharmaceutical masterpiece exerts its influence, stimulating insulin secretion contingent upon glucose levels and meticulously overseeing the delicate balance of blood glucose.
Online Inquiry
| CAT# | R2066 |
| CAS | 1492924-65-8 |
| Chemical Name | (2R)-2-amino-3-[1-[3-[3-(2-methoxyethoxy)propylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
InChI | InChI=1S/C16H27N3O7S/c1-25-7-8-26-6-2-4-18-13(20)3-5-19-14(21)9-12(15(19)22)27-10-11(17)16(23)24/h11-12H,2-10,17H2,1H3,(H,18,20)(H,23,24)/t11-,12?/m0/s1 |
InChI Key | DLVAZTPQKCTPLB-PXYINDEMSA-N |
Canonical SMILES | COCCOCCCNC(=O)CCN1C(=O)CC(C1=O)SCC(C(=O)O)N |
Isomeric SMILES | COCCOCCCNC(=O)CCN1C(=O)CC(C1=O)SC[C@@H](C(=O)O)N |
Write a review
Ask a question
My Review for Pegapamodutide
Required fields are marked with *
×
Ask a Question for Pegapamodutide
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
